Market Research Reports

What is Low and No Alcohol Beverages Market Size? Global Low and No Alcohol Beverages Market Size is valued at USD 30.48 Billion in 2025 and is predicted to reach USD 57.59 Billion by the year 2035 at a 6.8% CAGR during the forecast period for 2026 to 2035. Low and No Alcohol Beverages Market Size, Share & Trends Analysis Report By Product Category (Non-Alcoholic, RTD Mocktails, Functional Beverages), By Alcohol Content (No-Alcoho...

The Drug-coated Balloons Market Size is valued at 594.0 Million in 2022 and is predicted to reach 1301.8 Million by the year 2031 at a 9.2 % CAGR during the forecast period for 2023-2031. A drug-coated balloon (DCB) is defined as a semi-compliant angioplasty balloon layered with a cytotoxic chemotherapeutic agent. At present, paclitaxel-coated balloons are gaining popularity in commercial applications. In recent years, drug-coated balloons hav...

What is Plasma Proteins Market Size? Plasma Proteins Market Size is valued at 34.09 Billion in 2025 and is predicted to reach 76.20 Billion by the year 2035 at an 8.5% CAGR during the forecast period for 2026 to 2035. Plasma Proteins Market Size, Share & Trends Analysis Report By Product Type (Coagulation Factors, Immunoglobulin, Alpha-1 Proteinase Inhibitor, and Albumin), By Clinical Application, Region And Segment Forecasts, 2026 to 2035....

What is Neurodegenerative Disease Market Size? Global Neurodegenerative Disease Market Size is valued at USD 45.89 Billion in 2025 and is predicted to reach USD 78.75 Billion by the year 2035 at a 5.80% CAGR during the forecast period for 2026 to 2035. Neurodegenerative Disease Market Size, Share & Trends Analysis Report by disease indication (Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, Hun...

What is Asthma Spacers Market Size? Global Asthma Spacers Market Size is valued at USD 2.15 Billion in 2025 and is predicted to reach USD 4.10 Billion by the year 2035 at a 6.8% CAGR during the forecast period for 2026 to 2035. Asthma Spacers Market Size, Share & Trends Analysis Report By Brand (Space, Chamber Plus, A2A Spacer, Flo-Tone CR, Able Spacer, AeroChamber, Volumatic, Vortex, OptiChamber, Others), By Application, By Regio...

Left Appendage Occlusion Device Market Size is valued at 1358.98 Million in 2024 and is predicted to reach 8879.24 Million by the year 2034 at a 20.8% CAGR during the forecast period for 2025-2034. The left appendage occlusion device is used in procedures such as percutaneous transluminal left atrial appendage occlusion and thoracoscopic left atrial appendage closure. Left appendage occlusion device controls the electrical impulses during atri...

Global Phage Therapy Market is expected to grow at an 21.60% CAGR during the forecast period for 2026 to 2035. Phage Therapy Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Route of Administration (Oral, Topical, Rectal Route, Intravenous Route), by Targeted Bacteria (Escherichia coli, Staphylococcus aureus, Streptococcus, Pseudomonas aeruginosa, Salmonella, ...

Global Preclinical Oncology Models Market is valued at USD 1335.7 Million in 2024 and is predicted to reach USD 3733.0 Million by 2034, at a 10.9% CAGR during the forecast period 2025-2034. The rise of immuno-oncology therapy such as T cell therapy, bispecific antibodies, immune checkpoint modulators, and personalized cancer vaccines compels the need for unique preclinical and translational service solution. Recently advances in Immuno-oncolog...

What is HIV Drugs Market Size? Global HIV Drugs Market Size is valued at USD 40.21 Billion in 2025 and is predicted to reach USD 64.12 Billion by the year 2035 at a 5.0% CAGR during the forecast period for 2026 to 2035. HIV Drugs Market Size, Share & Trends Analysis Report By Drug Type (Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Integras...

The Gene Therapies For Rare Diseases Market is expected to grow at an 20.0 % CAGR during the forecast period for 2023-2031. Gene Therapy is playing a major role in rare disease management. Gene therapy in rare diseases is a specialized and targeted treatment that acts via the insertion of corrected genes into cells of an individual. Around 80 percent of rare diseases are accounted with genetic etiology. Gene therapy is considered as proven wit...

What is CBD Pet Market Size? CBD Pet Market Size is valued at USD 347.53 million in 2025 and is predicted to reach USD 2,868.57 million by the year 2035 at a 24.3% CAGR during the forecast period for 2026 to 2035. CBD Pet Market Size, Share & Trends Analysis Report, By Product (Therapeutic Grade (Pet Supplements, Pet CBD Oil), Food grade (Treats, Chews)), By Application (Joint Pain, Anxiety/Stress, Epilepsy, General Health/Wellness), End Us...

What is CAR-T Cell Therapy for Multiple Myeloma Market Size? Global CAR-T Cell Therapy for Multiple Myeloma Market Size is valued at USD 2.32 Billion in 2025 and is predicted to reach USD 9.28 Billion by the year 2035 at an 15.0% CAGR during the forecast period for 2026 to 2035. CAR-T Cell Therapy for Multiple Myeloma Market Size, Share & Trends Analysis Report By Therapy Type (Bb2121, JNJ-68284528 (LCAR-B38M),...

What is Oncolytic Virus Therapy Market Size? Gloabal Oncolytic Virus Therapy Market Size is valued at USD 17.35 Million in 2025 and is predicted to reach USD 157.20 Million by the year 2035 at a 25.6% CAGR during the forecast period for 2026 to 2035.  Oncolytic Virus Therapy Market Size, Share & Trends Analysis Report By Product (Herpes Simplex Virus (HSV), Adenoviruses, Vaccinia Virus, Vesicular Stom...

What is Capsule Endoscopy Market Size? Global Capsule Endoscopy Market Size is valued at USD 482.98 Million in 2025 and is predicted to reach USD 1049.93 Million by the year 2035 at a 8.2% CAGR during the forecast period for 2026 to 2035 Capsule Endoscopy Market Size, Share & Trends Analysis Report By Brand (CapsoCam Plus, Capso Retrieve, CapsoAccess, CapsoView, Check-cap, OMOM, MicroCam Regular, PillCam, EndoCapsule, Sayaka, Othe...

What is Alternative Proteins Market Size? Alternative Proteins Market Size is valued at USD 18.01 Bn in 2025 and is predicted to reach USD 61.69 Bn by the year 2035 at a 13.70% CAGR during the forecast period for 2026 to 2035. Alternative Proteins Market Size, Share & Trends Analysis Report, By Product (Plant Protein, Microbe-based Protein, Insect Protein), By Application (Food & Beverages, Clinical Nutrition, Animal Feed, Oth...

What is Allogeneic Cell Therapy Market Size? Allogeneic Cell Therapy Market Size is valued at 1.33 Million in 2025 and is predicted to reach 4.49 Billion by the year 2035 at a 13.30% CAGR during the forecast period for 2026 to 2035. Allogeneic Cell Therapy Market Size, Share & Trends Analysis Report By Type of Cell Therapy (Virus-Specific T-Cell, Stem Cell, Regulatory T-Cell), By Source of Cell, By Target Indication, By Therapeuti...

Global Immuno-Oncology Cell Therapy Market Size is valued at USD 11.9 Billion in 2024 and is predicted to reach USD 95.3 Billion by the year 2034 at a 23.2% CAGR during the forecast period for 2025-2034. Immuno-oncology cell therapies are a remarkably promising treatment for a different types of cancer patients. The approval of CAR-T cell therapy products represents one of the most significant breakthroughs in cancer since the introduction of ...

What is AI-Based Clinical Trial Solution Providers Market Size? Global AI-Based Clinical Trial Solution Providers Market Size is valued at USD 2.65 Billion in 2025 and is predicted to reach USD 21.03 Billion by the year 2035 at a 23.7% CAGR during the forecast period for 2026 to 2035. AI-Based Clinical Trial Solution Providers Market Size, Share & Trends Analysis Report By Target Therapeutics (Cardiovascular Disorders, CNS Disorde...

Rituximab Biosimilar Market is expected to grow at a 12.3% CAGR during the forecast period for 2025-2034. Rituximab is a chimeric anti-CD20 antibody that binds to the CD20 antigen present on the standard and malignant B cells surface. It is indicated for the treatment of blood cancer (CD20-positive) such as chronic lymphocytic leukemia and non-Hodgkin’s lymphoma, as well as an autoimmune disorder such as Rheumatoid arthritis. Rituximab i...

What is Trastuzumab Biosimilar Market Size? Trastuzumab Biosimilar Market is expected to grow at a 25.0 % CAGR during the forecast period for 2026 to 2035. Trastuzumab Biosimilar Market Size, Share & Trends Analysis Report By Product (Ogivri, Herzuma, Ontruzant, Trazimera, Other Pipeline Products), By Indication, By Route of Administration, By Molecule Type, Region And Segment Forecasts, 2026 to 2035. Trastuzumab Biosimilar Marke...